07-05-2025
30,000 boxes of heart and blood pressure tablets recalled in France
France's national authority for regulating medicine, the
Agence nationale de sécurité du médicament
(ANSM) published a statement recalling thousands of boxes of Lisinopril, a medicine that treats high blood pressure.
In a
statement
published on Tuesday, the ANSM explained that the recall was due to a printing defect.
"We have been informed by the Viatris laboratory of a printing defect on the blister packs of several batches of Lisinopril 5mg breakable tablets, which may lead to a risk of overdose.
"The inscription on the aluminium blister pack may be confusing, as it suggests that several tablets should be taken on certain days (...)
There is therefore a risk of patients taking too many tablets," they wrote.
According to the ANSM, risks in the event of an overdose include fatigue, balance problems, hypotension, and impaired kidney function.
A total of four batches of Lisinopril 5mg, or 32,640 boxes, are being recalled.
These are batch number 8172295 (28 tablets expiring in January 2026), 8189879 (28 tablets expiring in March 2027), 8172296 (84 tablets expiring in January 2026) and 8192737 (84 tablets expiring in March 2027).
Patients are asked to return affected boxes to their pharmacy.
Advertisement
ANSM also said 'the quality of the tablets [in the affected batches] is not in question'. The recall was solely to prevent possible overdoses prompted by the misprinted packaging.
If you are concerned your medication could be affected by a recall, you can always take it to your local pharmacy and ask the pharmacist for their advice.
READ MORE:
How you can check for food contamination warnings in France
